SCHEMBL6018095

SCHEMBL6018095

COC(=O)c1ccc(CN(Cc2nccn2C)C(=O)OC(C)(C)C)c2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
KDM4E B2RXH2 2/20 0.37
KCNA5 P22460 2/20 0.37
BRD4 O60885 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
NR4A2 P43354 1/20 0.34
CNR2 P34972 1/20 0.34
MAPT P10636 2/20 0.33
CNR1 P21554 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90B1 P14625 1/20 0.33
PTK2 Q05397 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018278 0.90 KCNA5 (0.38) LMNAKCNA5NPC1RAB9ACNR2
SCHEMBL6668439 0.84 RAB9A (0.36) LMNAKDM4EKCNA5NPC1RAB9A
SCHEMBL6645846 0.82 ALDH1A1 (0.40) LMNAKDM4EMAPTHDAC3HDAC1
SCHEMBL1638646 0.78 SMN1; SMN2 (0.49) LMNAKDM4EKCNA5NPC1RAB9A
SCHEMBL6018800 0.77 KDM4E (0.43) LMNAKDM4EBRD4NR4A2CNR2
SCHEMBL3107925 0.76 MAPK8 (0.39) LMNAKDM4EBRD4NPC1NR4A2
SCHEMBL6018246 0.74 KDM4E (0.47) LMNAKDM4EBRD4MAPT
SCHEMBL1636495 0.73 HDAC3 (0.40) KCNA5NPC1MEN1KMT2AHDAC3
SCHEMBL6018238 0.72 KDM4E (0.40) LMNAKDM4EKCNA5MAPTHDAC3
SCHEMBL6018093 0.70 MAP2K1 (0.34) LMNAKDM4ENR4A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098215-B2 Nitrogenous compounds and antiviral drugs containing the same KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-08-29 US disclosed
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same KUREHA CORPORATION (JP) 2004-05-13 US disclosed
EP-1273571-A1 NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME Kureha Chemical Industry Co., Ltd. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same NSUN2, ZC3HAV1L, PNP LMNA 1113/4885KDM4E 3110/4885KCNA5 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.